A prospective cohort analysis of gut microbial co-metabolism in Alaska Native and rural African people at high and low risk of colorectal cancer. Issue 2 (18th December 2019)

• Record Type: Journal Article
• Authors: Ocvirk, Soeren; Wilson, Annette S; Posma, Joram M; Li, Jia V; Koller, Kathryn R; Day, Gretchen M; Flanagan, Christie A; Otto, Jill Evon; Sacco, Pam E; Sacco, Frank D; Sapp, Flora R; Wilson, Amy S; Newton, Keith; Brouard, Faye; DeLany, James P; Behnning, Marissa; Appolonia, Corynn N; Soni, Devavrata; Bhatti, Faheem; Methé, Barbara; Fitch, Adam; Morris, Alison; Gaskins, H Rex; Kinross, James; Nicholson, Jeremy K; Thomas, Timothy K; O'Keefe, Stephen J D
• Is Part Of: American journal of clinical nutrition. Volume 111:Issue 2(2020)
• Page Start: 406
• Page End: 419
• Publication Date: 2019-12-18
• Subjects: colorectal cancer -- gut microbiota -- dietary fiber -- short-chain fatty acids -- butyrate -- bile acids -- deoxycholic acid -- Alaska Native people -- rural African people; Diet therapy -- Periodicals; Nutrition -- Periodicals; Dietetics -- Periodicals; 613.205
• DOI: 10.1093/ajcn/nqz301
• Languages: English
• ISSNs: 0002-9165

Abstract

ABSTRACT: Background: Alaska Native (AN) people have the world's highest recorded incidence of sporadic colorectal cancer (CRC) (∼91:100, 000), whereas rural African (RA) people have the lowest risk (<5:100, 000). Previous data supported the hypothesis that diet affected CRC risk through its effects on the colonic microbiota that produce tumor-suppressive or -promoting metabolites. Objectives: We investigated whether differences in these metabolites may contribute to the high risk of CRC in AN people. Methods: A cross-sectional observational study assessed dietary intake from 32 AN and 21 RA healthy middle-aged volunteers before screening colonoscopy. Analysis of fecal microbiota composition by 16S ribosomal RNA gene sequencing and fecal/urinary metabolites by 1 H-NMR spectroscopy was complemented with targeted quantification of fecal SCFAs, bile acids, and functional microbial genes. Results: Adenomatous polyps were detected in 16 of 32 AN participants, but not found in RA participants. The AN diet contained higher proportions of fat and animal protein and less fiber. AN fecal microbiota showed a compositional predominance of Blautia and Lachnoclostridium, higher microbial capacity for bile acid conversion, and low abundance of some species involved in saccharolytic fermentation (e.g., Prevotellaceae, Ruminococcaceae ), but no significant lack of butyrogenic bacteria. Significantly lower concentrations of tumor-suppressive butyrate (22.5 ± 3.1 compared with 47.2 ± 7.3 SEM µmol/g) coincided with significantly higher concentrations of tumor-promoting deoxycholic acid (26.7 ± 4.2 compared with 11 ± 1.9 µmol/g) in AN fecal samples. AN participants had lower quantities of fecal/urinary metabolites than RA participants and metabolite profiles correlated with the abundance of distinct microbial genera in feces. The main microbial and metabolic CRC-associated markers were not significantly altered in AN participants with adenomatous polyps. Conclusions: The low-fiber, high-fat diet of AN people and exposure to carcinogens derived from diet or environment are associated with a tumor-promoting colonic milieu as reflected by the high rates of adenomatous polyps in AN participants.